Lawmakers have agreed to renew a key global AIDS relief program for one more year as part of the government’s spending package that must earn
Kentucky passed a law allowing insurers to encourage patients to try biosimilar medicines before covering the branded equivalent to expand access to lower-cost medicines. Governor
Novo Nordisk is putting up about $556 million, or 4 billion yuan, to amp up its manufacturing capacity in China, the company announced Tuesday. Novo
The FDA is proposing to tighten its regulations on compounding three categories of drugs that the agency determined are too difficult to compound, according to
The FDA is spelling out its game plan for regulating artificial intelligence in medical products, according to a paper published Friday. The seven-page report was
Leaders on the Senate Finance Committee are making a push to pass reforms to pharmacy benefit managers, which have had a target on their backs
The US has so far doled out about $3 billion on three of Sarepta Therapeutics’ therapies for Duchenne muscular dystrophy, even as all three of
Just days after Congress passed the FDA’s fiscal year 2024 appropriations package at the 11th hour, the Biden administration is asking for a bump in
The pharma industry got a glimpse Thursday night of what four more years of the Biden administration could look like. And they did not like
Bristol Myers Squibb won another approval for its blockbuster cancer drug Opdivo, this time to treat a type of bladder cancer in combination with chemotherapies,